University College, London
Clinical trials sponsored by University College, London, explained in plain language.
-
Keytruda after chemo shows promise in Hard-to-Treat ovarian cancer
Disease control CompletedThis phase 2 trial tested whether the immunotherapy drug pembrolizumab (Keytruda) could help keep cancer from growing in people with platinum-resistant ovarian, fallopian tube, or peritoneal cancer. After initial chemotherapy with paclitaxel, 20 participants received pembrolizuma…
Phase: PHASE2 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 24, 2026 11:06 UTC
-
Robot or scalpel? new study tests best bladder cancer surgery
Disease control CompletedThis study compared two types of surgery to remove the bladder in people with bladder cancer: one done with a robot and one done as open surgery. About 339 patients took part across multiple hospitals. The main goal was to see which approach let patients spend more days at home a…
Phase: NA • Sponsor: University College, London • Aim: Disease control
Last updated Jun 23, 2026 12:00 UTC
-
New hope for stroke survivors with rare clotting disorder: rivaroxaban vs warfarin
Disease control CompletedThis study tested whether the drug rivaroxaban works as well as warfarin to prevent further brain damage in people who have had a stroke due to antiphospholipid syndrome (APS), a condition that causes abnormal blood clotting. About 40 participants took either rivaroxaban or warfa…
Phase: PHASE2 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 22, 2026 12:09 UTC
-
New drug combo shows promise in head and neck cancer trial
Disease control CompletedThis early-stage trial tested the safety of adding olaparib to standard chemotherapy and radiation for people with advanced head and neck cancer. Sixteen patients took part to find the best dose and see how well they tolerated the combination. The goal was to control the disease,…
Phase: PHASE1 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 22, 2026 12:09 UTC
-
Could a diabetes drug be the key to slowing Parkinson's?
Disease control CompletedThis study tested whether exenatide, a drug already used for type 2 diabetes, can slow the progression of Parkinson's disease. About 194 people with early-stage Parkinson's received either exenatide or a placebo once a week for two years. The goal was to see if the drug could pro…
Phase: PHASE3 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 22, 2026 12:02 UTC
-
New bead treatment shows promise for anal fistulas
Disease control CompletedThis early study tested a new treatment for perianal fistulas (abnormal tunnels near the anus) using tiny absorbable beads called TIPS microspheres. The beads were placed into the fistula during a standard surgical procedure to see if they are safe and help the fistula heal natur…
Phase: NA • Sponsor: University College, London • Aim: Disease control
Last updated Jun 17, 2026 12:09 UTC
-
New hope for lymphoma patients who Can't handle standard chemo
Disease control CompletedThis study tested two different drug combinations for people with a type of blood cancer called diffuse large B-cell lymphoma (DLBCL) who cannot take the usual strong chemotherapy. The trial compared a newer drug (inotuzumab ozogamicin) plus standard therapy against another commo…
Phase: PHASE2 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 10, 2026 13:29 UTC
-
Lung cancer trial matches drugs to tumor DNA
Disease control CompletedThis study tested whether giving drugs based on the genetic makeup of a person's lung cancer could help control the disease. About 50 adults with advanced non-small cell lung cancer received either immunotherapy (atezolizumab) alone or with chemotherapy, or targeted drugs like ve…
Phase: PHASE2 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 08, 2026 13:10 UTC
-
New combo therapy shows promise for incurable head and neck cancer
Disease control CompletedThis study looked at whether adding cetuximab to avelumab works better than avelumab alone for people with advanced head and neck cancer that has come back or spread. The cancer in these patients is not curable, and average survival is less than a year. The trial first checked th…
Phase: PHASE2 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 03, 2026 12:06 UTC
-
New scoring tool aims to speed up appendicitis surgery decisions
Diagnosis CompletedThis study looked at whether the Appendistat Score (APS) can accurately identify patients with complicated appendicitis who need urgent surgery. Researchers reviewed records of 592 patients who had their appendix removed. They compared the APS score to the final lab results to se…
Sponsor: University College, London • Aim: Diagnosis
Last updated Jun 23, 2026 12:00 UTC
-
New drug could shield preemie lungs from chronic disease
Prevention CompletedThis early-stage trial tested a new drug called rfhSP-D in 18 premature babies born before 30 weeks. The goal was to find the safest dose that might prevent chronic lung disease, a common complication in preemies. The drug was given along with standard care to babies on breathing…
Phase: PHASE1 • Sponsor: University College, London • Aim: Prevention
Last updated Jun 22, 2026 11:54 UTC
-
New app aims to reboot language after stroke
Symptom relief CompletedThis study tested an app called iTalkBetter for people who have trouble finding words after a stroke. 31 participants used the app to practice naming specific items. The goal was to see if the app could improve word retrieval for those practiced items. This small trial helps unde…
Phase: NA • Sponsor: University College, London • Aim: Symptom relief
Last updated Jun 25, 2026 12:08 UTC
-
Talking therapy could ease menopause mood swings without hormones
Symptom relief CompletedThis study tested whether a 6-session online group program called Compassionate Mind Training (CMT) can improve wellbeing in women aged 40-60 going through menopause. The therapy aims to reduce self-criticism and shame by building self-compassion. Researchers enrolled 38 women to…
Phase: NA • Sponsor: University College, London • Aim: Symptom relief
Last updated Jun 25, 2026 12:08 UTC
-
Parkinson's patients get new hope: group therapy targets anxiety and depression
Symptom relief CompletedThis study tested three types of group psychological therapy for people with Parkinson's: one for adjusting to diagnosis, one for anxiety and depression, and one for memory and thinking problems. 138 participants took part, and the therapy was designed to be delivered by non-ment…
Phase: NA • Sponsor: University College, London • Aim: Symptom relief
Last updated Jun 24, 2026 11:02 UTC
-
App helps dementia patients recall loved Ones' names
Symptom relief CompletedThis study tested a web-based app called Gotcha! designed to help people with mild-to-moderate dementia remember names of people they know. 48 participants practiced daily for 6 weeks using a tablet at home. The goal was to see if the therapy improves name recall and whether it c…
Phase: NA • Sponsor: University College, London • Aim: Symptom relief
Last updated Jun 18, 2026 11:53 UTC
-
New hope for menopause brain fog: simple cognitive program shows promise
Symptom relief CompletedThis study tested a cognitive intervention to help manage 'brain fog'—memory and concentration problems—during menopause. It involved 33 women aged 40-60 who reported cognitive difficulties. The goal was to see if the program was feasible and acceptable, offering a non-hormonal o…
Phase: NA • Sponsor: University College, London • Aim: Symptom relief
Last updated Jun 18, 2026 11:52 UTC
-
Can a simple pill combo soften radiation scars? new trial explores.
Symptom relief CompletedThis study tested whether two common drugs (pentoxifylline and vitamin E) can help reduce fibrosis—hardening of tissues—that often occurs after radiation for head and neck cancer. Fifty adults who had radiation at least a year ago and were cancer-free took either the drug combo p…
Phase: PHASE1 • Sponsor: University College, London • Aim: Symptom relief
Last updated Jun 16, 2026 12:50 UTC
-
Stroke survivors see big gains with intensive arm training, new study finds
Symptom relief CompletedThis study tested whether 90 hours of intensive arm therapy over 3 weeks can improve arm function in people who had a stroke at least 6 months earlier. 105 participants were split into two therapy groups (a standard program or a video-game based program) or a wait-list group that…
Phase: PHASE2 • Sponsor: University College, London • Aim: Symptom relief
Last updated Jun 12, 2026 12:08 UTC
-
Can a simple meditation ease PTSD and sleepless nights?
Symptom relief CompletedThis study tested whether a guided meditation called yoga nidra is practical and helpful for people with PTSD and insomnia. Sixty adults who had experienced a stressful or traumatic event and had trouble sleeping took part. They listened to online recordings daily for 8 weeks, an…
Phase: NA • Sponsor: University College, London • Aim: Symptom relief
Last updated Jun 09, 2026 12:10 UTC